|
MEDP | Medpace Holdings, Inc. |
|
|
MEDP | Medpace Holdings, Inc. |
| Services-Commercial Physical & Biological Research |
| Book value per $ invested | $ 0.08 |
| Leverage | 57.71% |
| Market Cap | $ 10.5B |
| PE | 29.05 |
| Dividend Yield | 0.00% |
| Profit | $ 362.9m |
| Margin | 17.62% |
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company is headquartered in Cincinnati, Ohio.